The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex (Q40668417)

22 September 2017

title

The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex (English)

1 reference

22 September 2017

Zhengliang L Wu

1

1 reference

22 September 2017

Lijuan Zhang

2

1 reference

22 September 2017

Tomio Yabe

3

1 reference

22 September 2017

B Kuberan

4

1 reference

22 September 2017

David L Beeler

5

1 reference

22 September 2017

Andre Love

6

1 reference

22 September 2017

Robert D Rosenberg

7

1 reference

22 September 2017

language of work or name

English

0 references

publication date

25 February 2003

1 reference

Journal of Biological Chemistry

22 September 2017

published in

1 reference

22 September 2017

volume

278

1 reference

22 September 2017

issue

19

1 reference

22 September 2017

page(s)

17121-17129

1 reference

Functions of cell surface heparan sulfate proteoglycans

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Order out of chaos: assembly of ligand binding sites in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Specificities of heparan sulphate proteoglycans in developmental processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

The elusive functions of proteoglycans: in vivo veritas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Regulation of signal transduction and signal diversity by receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Identification of a new fibroblast growth factor receptor, FGFR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Heparin structure and interactions with basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Structural interactions of fibroblast growth factor receptor with its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Dimerization of cell surface receptors in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Regulated diversity of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

A new strategy for defining critical functional groups on heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

The effect of precursor structures on the action of glucosaminyl 3-O-sulfotransferase-1 and the biosynthesis of anticoagulant heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Structural basis for FGF receptor dimerization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Nature of the interaction of heparin with acidic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Fibroblast Growth Factor Receptors 1 and 2 Interact Differently with Heparin/Heparan Sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

FGF signaling in skeletal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

An essential heparin-binding domain in the fibroblast growth factor receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Distinct heparan sulfate glycosaminoglycans are responsible for mediating fibroblast growth factor-2 biological activity through different fibroblast growth factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Multivalent Ligand-Receptor Binding Interactions in the Fibroblast Growth Factor System Produce a Cooperative Growth Factor and Heparin Mechanism for Receptor Dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212590200

21 January 2018

Identifiers

DOI

10.1074/JBC.M212590200

1 reference

22 September 2017

1 reference